Health Portugal Brokerage Event 2024

14–18 Oct 2024 | Porto, Portugal

Register
Register
Register

PartnershipUpdated on 9 October 2024

Test your cell cultures in xeno-free alternatives

Catarina Custódio

CEO at Metatissue

Ílhavo, Portugal

About

This disruptive and scalable technology has the potential to be used in numerous applications due to the flexibility of the biomatrix, which can be formulated as a hydrogel, microparticle, sponge, microsponge, and bioink. The applications of Metatissue’s products include, but are not limited to, fundamental cell culture research (e.g., cell encapsulation, spheroid and organoid culture), cancer and stem cell research, cell expansion, drug screening and development, disease modeling, organon-a-chip, 3D bio-printing, and tissue engineering, underlining the immense research and clinical potential.

The innovation potential of hPLMA relies on the following key features: ● Xeno-free – the technology provides a xeno-free alternative to the current commercially available animal-derived products; ● Personalized – the platforms may be tailored with the characteristics needed for a certain application; ● Multifunctional – human-derived tissues and fluids contain native human-derived proteins and growth factors providing structural and biochemical support in 3D tissue models; ● Tuneable mechanical performance - both the mechanical properties and water uptake can be easily manipulated; ● Autologous/allogenic – humanized materials prepared from multiple donor units that are pooled during manufacturing to minimize lot-to-lot variability, compliant with standardization requirements; ● Versatile and suitable for human use - humanized product allows for the proper development of multiple tissues and disease models;

Similar opportunities